News | August 20, 2009

TCT 2009 Offers Key Information on Latest PCI Advances

August 21, 2009 – The Transcatheter Cardiovascular Therapeutics (TCT) 2009 symposium is set for Sept. 21-25, at The Moscone Center?in San Francisco, Calif.

This year's TCT was developed to reflect the advances and changes in the field while maintaining a long-standing commitment to TCT's core values: focus on therapy innovation, trust in evidence-based medicine, and dedication to putting patients first. The event includes sessions on the latest advancements in cardiac diagnostics, imaging, coronary and peripheral stenting interventions, percutaneous structural heart repair. Live interventional procedures will be broadcast from around the world in several large-screen theaters. The exhibit floor will highlight the latest technology and devices from manufacturers.

This year’s TCT will include a greater focus on health information technologies with the passage earlier this year of the federal Health Information Technology for Economic and Clinical Health (HITECH) Act, which provides billions in federal funding for electronic medical upgrades.

This year’s TCT will also include a tract for cardiothoracic and vascular surgeons. The in-depth, five-day meeting focusing on novel and advanced surgical techniques and including a thorough introductory course on transcatheter coronary and valve disease therapies for the surgeon. The practice of cardiovascular surgery for coronary artery and valve disease is being transformed by lesser invasive endovascular and robotic approaches, new insights from pre-, post-, and intra-operative imaging, novel anastomotic connectors and ventricular support devices, and an increasing recognition of the advantages of hybrid surgical and percutaneous procedures. Advances in endograft technology and technique have also revolutionized the treatment of aortic aneurysms and dissection.

The TCT for Nurses and Technologists at TCT 2009 will provide a forum for discussion of the latest advances in interventional, pharmacologic, and clinical/administrative strategies for the management of the cardiovascular patient. Content is presented utilizing didactic lectures, case presentations, panel discussions, hands-on workshops, and breakout sessions.

For more information, event schedules, lists of exhibiting vendors, session details, satellite symposia, and registration, visit

Related Content

SherpaPak Cardiac Transport System Cleared for Pediatric and Small Donor Hearts
Technology | Cardiovascular Surgery | February 01, 2019
Paragonix Technologies Inc. recently received clearance from the U.S. Food and Drug Administration (FDA) for a design...
Transplanting Pig Hearts Into Humans One Step Closer. A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it would greatly alleviate shortages of donor human hearts.

A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it would greatly alleviate shortages of donor human hearts.

News | Cardiovascular Surgery | December 11, 2018
The scientific journal Nature recently published an article from Munich University Hospital which describes the long-...
Bilateral Artery Use Does Not Improve 10-Year CABG Outcomes
News | Cardiovascular Surgery | September 06, 2018
While it is firmly established that the use of one internal thoracic artery can improve life expectancy in coronary...
Mandatory Public Coronary Artery Bypass Grafting Reporting Associated With Better Patient Outcomes
News | Cardiovascular Surgery | April 30, 2018
Mandatory public reporting of coronary artery bypass grafting (CABG) results in Massachusetts was associated with...
Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery | September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
ClearFlow Inc. Announces Positive U.S. Clinical Trial Results
News | Cardiovascular Surgery | September 08, 2017
September 8, 2017 — ClearFlow Inc.
Videos | Cardiovascular Surgery | July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Intensive Glycemic Control Program Produces Significant Per-Patient Cost Savings for CABG Surgery
News | Cardiovascular Surgery | May 25, 2017
A new study from Emory University observed a near-20 percent reduction in perioperative complications, a 1.2-day...
Risk of Heart Transplant Rejection Reduced by Desensitizing Patient Antibodies
News | Cardiovascular Surgery | May 23, 2017
The risk of heart transplant rejection can be reduced by desensitizing patient antibodies, according to research...
Overlay Init